Ivabradine for coronary artery disease and/or heart failure—a protocol for a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis

BACKGROUND: Coronary artery disease and heart failure are both highly prevalent diseases with a global prevalence of 93 million and 40 million. These patients are at increased risk of morbidity and mortality. The management of these patients involves medical therapy, and both diseases can be treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Maagaard, M., Nielsen, E. E., Gluud, C., Jakobsen, J. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357471/
https://www.ncbi.nlm.nih.gov/pubmed/30709418
http://dx.doi.org/10.1186/s13643-019-0957-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357471/
https://www.ncbi.nlm.nih.gov/pubmed/30709418
http://dx.doi.org/10.1186/s13643-019-0957-0

Ejemplares similares